Backed by senior members of the founding family, the traditionalists among Takeda’s investors have made their last stand in the fight against remaking the 237-year-old company as a global heavyweight.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,